Journey Medical Corporation
DERM
$6.99
-$0.36-4.90%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 55.24M | 55.13M | 57.77M | 58.42M | 60.53M |
| Total Other Revenue | 1.00M | 1.00M | 0.00 | 19.26M | 19.47M |
| Total Revenue | 56.24M | 56.13M | 57.77M | 77.68M | 80.00M |
| Cost of Revenue | 18.85M | 20.07M | 20.08M | 21.22M | 22.45M |
| Gross Profit | 37.39M | 36.07M | 37.70M | 56.46M | 57.55M |
| SG&A Expenses | 42.35M | 40.20M | 39.99M | 37.23M | 39.04M |
| Depreciation & Amortization | 4.49M | 4.24M | 4.58M | 4.58M | 4.58M |
| Other Operating Expenses | -4.55M | -4.55M | -- | -- | -- |
| Total Operating Expenses | 63.15M | 69.81M | 75.79M | 75.56M | 79.46M |
| Operating Income | -6.91M | -13.68M | -18.02M | 2.12M | 541.00K |
| Income Before Tax | -8.24M | -14.61M | -18.21M | 1.06M | -3.94M |
| Income Tax Expenses | 61.00K | 61.00K | 126.00K | 221.00K | 221.00K |
| Earnings from Continuing Operations | -8.30 | -14.67 | -18.34 | 0.84 | -4.16 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.30M | -14.67M | -18.34M | 843.00K | -4.16M |
| EBIT | -6.91M | -13.68M | -18.02M | 2.12M | 541.00K |
| EBITDA | -3.24M | -10.25M | -14.76M | 5.38M | 4.05M |
| EPS Basic | -0.39 | -0.74 | -0.93 | 0.10 | -0.20 |
| Normalized Basic EPS | -0.28 | -0.50 | -0.61 | 0.07 | -0.01 |
| EPS Diluted | -0.40 | -0.75 | -0.94 | -0.02 | -0.31 |
| Normalized Diluted EPS | -0.28 | -0.50 | -0.61 | 0.00 | -0.08 |
| Average Basic Shares Outstanding | 84.45M | 81.60M | 78.98M | 76.86M | 74.87M |
| Average Diluted Shares Outstanding | 84.45M | 81.60M | 78.98M | 79.48M | 77.49M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |